| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $882.5M | +8.5% |
| Cost of Revenue | $413.2M | -1.0% |
| Gross Profit | $469.3M | +18.6% |
| R&D Expense | $5.8M | +48.7% |
| SG&A Expense | $63.2M | +14.5% |
| Operating Income | $343.6M | +4.6% |
| Pre-tax Income | $389.0M | +16.0% |
| Income Tax | $58.9M | -4.8% |
| Net Income | $330.1M | +20.7% |
| EPS (Basic) | $1.84 | +15.7% |
| EPS (Diluted) | $1.58 | +16.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $237.6M | +25.7% |
| Accounts Receivable | $106.7M | -24.6% |
| Inventory | $217.5M | +42.8% |
| Current Assets | $648.2M | +19.2% |
| Total Assets | $3.23B | +55.7% |
| Current Liabilities | $268.6M | +80.6% |
| Long-term Debt | $302.0M | +24.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $297.3M | -34.6% |
| Capital Expenditures | $327.1M | -2.9% |
| Investing Cash Flow | -$228.3M | +37.4% |
| Financing Cash Flow | -$20.4M | -63.2% |
| Free Cash Flow | -$29.8M | -125.3% |
| Total Liabilities |
| $946.3M |
| +49.9% |
| Stockholders' Equity | $1.78B | +23.6% |